Axsome Therapeutics, Inc.
NASDAQ:AXSM
87.25 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Axsome Therapeutics, Inc. |
Symbool | AXSM |
Munteenheid | USD |
Prijs | 87.25 |
Beurswaarde | 4,188,017,450 |
Dividendpercentage | 0% |
52-weken bereik | 55.02 - 98.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Herriot Tabuteau M.D. |
Website | https://www.axsome.com |
An error occurred while fetching data.
Over Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)